# Enveda Secures $311M to Bring More Nature-derived AI Drugs Into Clinical Trials

> **Platform:** [SPIDITS AI](https://spidits.com/) — Real-Time AI News & Market Intelligence  
> **Published:** 2026-09-23T12:00:00.000Z  
> **Category:** FUNDING  
> **Impact Score:** 180/100  
> **Primary Source:** [TechCrunch AI](https://techcrunch.com/2026/09/23/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials)  
> **Canonical Citation:** [https://spidits.com/timeline/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical](https://spidits.com/timeline/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical)

## Executive Summary
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

## Referenced Coverage & Sources
- **[TechCrunch AI](https://techcrunch.com/2026/09/23/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials)**: Enveda secures $311M to bring more nature-derived AI drugs into clinical trials — _The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s._

---
*Synthesized by SPIDITS AI Market Intelligence Desk. Track live AI news, model releases, and funding: [https://spidits.com](https://spidits.com)*